• Nachrichtendetail
• 

27.06.2024 14:15:19 - dpa-AFX: *LIGAND PARTNER VERONA PHARMA ANNOUNCES FDA APPROVAL OF OHTUVAYRE FOR MAINTENANCE TREATMENT OF COPD

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	78,500	02.07.24 08:20:56	+0,500	+0,64%	78,500	79,500	78,500	78,000